{"data":{"id":"us-de/16-del.-c.-4904","jurisdiction":"us-de","citation":"16 Del. C. § 4904","heading":"Prescribing or administering of laetrile.","body":"(a) No hospital nor health facility may interfere with the physician-patient relationship by restricting or forbidding the use of laetrile (amygdalin, Vitamin B-17) when prescribed or administered by a physician, surgeon, osteopath or other person engaged in the “practice of medicine,” as that term is defined in § 1702 of Title 24 and/or when requested by a patient, unless the substance as prescribed or administered by the physician or medical practitioner is found to be harmful by the Board of Medical Licensure and Discipline in a public hearing which complies with the Freedom of Information Act [Chapter 100 of Title 29].\n(b) No physician, surgeon, osteopath or other person engaged in the “practice of medicine,” as that term is defined in § 1702 of Title 24 shall be subject to disciplinary action solely for the prescribing or administering of laetrile (amygdalin, Vitamin B-17) to a patient under the physician's, surgeon's, osteopath's or other person's care who has requested the substance.\n(c) Under this section laetrile shall not be considered a medical drug, but shall be considered a natural food substance.","path":["Title 16. Health and Safety","Food and Drugs","CHAPTER 49. Natural Food Substances"],"source_url":"https://delcode.delaware.gov/title16/c049/index.html#4904","current_through":"2026-08-10 (85 Del. Laws, c. 421, 424)","vintage":"","retrieved_at":"2026-09-05T23:02:21Z","sha256":"8b3a2f679fdbf9ba8dbbcb4f832db7aa8c21cbe1b0e0a823f153ddc2594999a1","source_id":"us-de","stale":true,"prev":"us-de/16-del.-c.-4903","next":"us-de/16-del.-c.-4905"},"notice":"GroundRules: Original legal text. Not legal advice."}